Effect of Citalopram on Reflux Episodes in Healthy Volunteers
NCT03746691 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2018-11-20
Summary
Citalopram is sometimes used in the treatment for gastro-esophageal reflux disease, however, there are no empirical data to support this. The investigators would like to know if citalopram has an effect on the lower esophageal sphincter pressure, transient lower esophageal sphincter relaxations and reflux episodes. The investigators will investigate this by performing high resolution impedance manometry in healthy volunteers before and after a solid meal. This will be compared to placebo, in a cross-over, randomized, double-blind condition.
Conditions
- Gastro Esophageal Reflux
Interventions
- DRUG
-
Citalopram HCl
Citalopram HCl IV 20 mg in 100 ml saline will be infused IV over the course of 30 minutes. Volunteers will receive a standard meal, and recordings using high resolution impedance manometry, will be continued for 2 hours.
- DRUG
-
Placebos
Placebo (100 ml saline IV) will be infused IV over the course of 30 minutes. Volunteers will receive a standard meal, and recordings using high resolution impedance manometry, will be continued for 2 hours.
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Jan Tack, Prof. · Universitaire Ziekenhuizen KU Leuven
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-01
- Primary Completion
- 2017-07-31
- Completion
- 2017-07-31
Countries
- Belgium
Study Locations
More Related Trials
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Physiology of GERD and Treatment Response
NCT04292470 ·Status: COMPLETED ·Phase: NA
-
Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers
NCT03402984 ·Status: COMPLETED ·Phase: NA
-
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers
NCT02674256 ·Status: COMPLETED ·Phase: PHASE4
-
A Placebo Controlled Trial With Baclofen for the Treatment of GERD Patients With Incomplete PPI Response
NCT03835442 ·Status: COMPLETED ·Phase: NA
-
Cognitive-behavioral Therapy for the Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
NCT06939465 ·Status: RECRUITING ·Phase: NA
-
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
NCT00394472 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux
NCT00462137 ·Status: COMPLETED
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
NCT00498082 ·Status: UNKNOWN
-
Effect of Coffee on Gastro-Esophageal Disease in Patients With Symptoms of Reflux
NCT00584259 ·Status: COMPLETED ·Phase: NA
-
Effect of Baclofen in Management of Patients With Gastroesophageal Reflux Disease Symptoms
NCT07063576 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Utilization of Anti-reflux Treatment and Course of Illness Leading to Reoperation
NCT03536169 ·Status: COMPLETED
-
How Reflux Medications Affect the Microbiome of Infants
NCT03747991 ·Status: COMPLETED
-
Effect of MIST on Esophageal Sensitivity in Patients With rGERD
NCT05429034 ·Status: UNKNOWN ·Phase: NA
-
Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
NCT06778824 ·Status: RECRUITING ·Phase: NA
-
Treatment of Newly Diagnosed Gastroesophageal Reflux Disease in a National Population-based Cohort
NCT03524781 ·Status: COMPLETED
-
Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease
NCT06151067 ·Status: COMPLETED
-
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
NCT01601379 ·Status: COMPLETED
-
The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients
NCT00524251 ·Status: COMPLETED
-
Acid Pocket: Position and Aspiration
NCT02199002 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
NCT00323817 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors
NCT01265550 ·Status: COMPLETED ·Phase: PHASE3